RECENT POSTS

Glioblastoma Multiforme (GBM)

26

Mar, 2019

About Glioblastoma (GBM)

By: | Tags: | Comments: 0

Overview Tumour Group: Gliomas WHO Grade: Grade IV Prevalence/Incidence: The incidence of glioblastoma multiforme (GBM) is 2 to 3 per 100,000 people in the United States and Europe. GBM accounts for 12 to 15% of all intracranial tumours and…

READ MORE
Lung Cancer Screening in Real World Has High False-Positive Rate

26

Mar, 2019

Lung Cancer Screening in Real World Has High False-Positive Rate

By: | Tags: | Comments: 0

By Kelly YoungEdited by: David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD A pair of studies in JAMA Internal Medicine illustrate the difficulties of implementing lung cancer screening. In the first, eight Veterans Health Administration medical centers identified and screened patients using low-dose computed tomography (LDCT). Over 2100 patients who were eligible for screening based on smoking history and other factors completed LDCT. Overall, 60% had nodules, but just 1.5%…

READ MORE

29

Nov, 2016

A supramolecular indicator displacement assay for acetyl amantadine

By: | Tags: | Comments: 0

A supramolecular indicator displacement assay for acetyl amantadine, a proxy biomarker for spermidine/spermine N1-acetyltransferase (SSAT) activity Introduction Cancer is a leading cause of death worldwide.1 The number of new cancer cases is expected to increase 40% in the next 15 years in Canada due to an aging and growing population.2 Lung cancer is the most commonly diagnosed in this country (excluding nonmelanoma skin cancers) and accounts for 14% of all…

READ MORE